Muljibhai Patel Urological Hospital
Nadiād, Gujarat, 387001, India
NCT Number: NCT03167294
Single-arm prospective, interventional clinical trial. Results will be compared to a historical control in the treatment of benign prostatic hyperplasia
Looking for future studies?
Notify Me50 year–80 year
Male
Interventional
Not applicable
Nadiād, Gujarat, 387001, India
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Aquablation
Time frame: 6 months
The primary device performance endpoint is completion of the intended surgical procedure.
Time frame: 6 months
The primary safety endpoint of the study is the perioperative complication rate
PROCEPT BioRobotics
Industry
PROCEPT AQUABEAM Study for the Treatment of Benign Prostatic Hyperplasia (ABS)
Acronym: ABS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07103278
Benign Prostatic Hyperplasia, Genital Diseases
Seoul, South Korea
View Trial DetailsNCT06589154
Benign Prostatic Hyperplasia, Genital Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT07715448
Benign Prostatic Hyperplasia, Ejaculatory Dysfunction
Banī Suwayf, Beni Suef Governorate, Egypt
View Trial DetailsNCT05200065
Benign Prostatic Hyperplasia, Genital Diseases
Cairo, Cairo Governorate, Egypt
View Trial Details